{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:58:08Z","timestamp":1790485088907,"version":"4.1.0"},"reference-count":71,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3892\/or.2017.5362","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T02:13:18Z","timestamp":1484014398000},"page":"737-746","source":"Crossref","is-referenced-by-count":85,"title":["NF-\u03baB inhibition is associated with OPN\/MMP-9 downregulation in cutaneous melanoma"],"prefix":"10.3892","volume":"37","author":[{"given":"Claudio","family":"Guarneri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bevelacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Polesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Falzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia S.","family":"Cannav\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios A.","family":"Spandidos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Malaponte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Libra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,1,10]]},"reference":[{"key":"key20180107224724_b1-or-37-02-0737","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20180107224724_b2-or-37-02-0737","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000368775","article-title":"Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients","volume":"230","author":"Fava","year":"2015","journal-title":"Dermatology"},{"key":"key20180107224724_b3-or-37-02-0737","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3892\/ijo.2014.2481","article-title":"Emerging targeted therapies for melanoma treatment (Review)","volume":"45","author":"Russo","year":"2014","journal-title":"Int J Oncol"},{"key":"key20180107224724_b4-or-37-02-0737","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.hoc.2009.03.009","article-title":"Melanoma and immunotherapy","volume":"23","author":"Eggermont","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20180107224724_b5-or-37-02-0737","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3892\/ijo.2016.3594","article-title":"Targeting the PI3K\/AKT\/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor","volume":"49","author":"Caporali","year":"2016","journal-title":"Int J Oncol"},{"key":"key20180107224724_b6-or-37-02-0737","doi-asserted-by":"crossref","first-page":"954","DOI":"10.18632\/oncotarget.652","article-title":"Mutations and deregulation of Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR cascades which alter therapy response","volume":"3","author":"McCubrey","year":"2012","journal-title":"Oncotarget"},{"key":"key20180107224724_b7-or-37-02-0737","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3892\/ijo.2014.2491","article-title":"Towards combinatorial targeted therapy in melanoma: From pre-clinical evidence to clinical application (Review)","volume":"45","author":"Grazia","year":"2014","journal-title":"Int J Oncol"},{"key":"key20180107224724_b8-or-37-02-0737","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"key20180107224724_b9-or-37-02-0737","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/PAP.0b013e3182976c94","article-title":"Ras, Raf, and MAP kinase in melanoma","volume":"20","author":"Solus","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"key20180107224724_b10-or-37-02-0737","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.4161\/cc.4.10.2026","article-title":"Analysis of BRAF mutation in primary and metastatic melanoma","volume":"4","author":"Libra","year":"2005","journal-title":"Cell Cycle"},{"key":"key20180107224724_b11-or-37-02-0737","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3892\/or.2014.2977","article-title":"Analysis of the B-RafV600E mutation in cutaneous melanoma patients with occupational sun exposure","volume":"31","author":"Candido","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180107224724_b12-or-37-02-0737","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1947601910373795","article-title":"The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-\u03baB\/Snail\/RKIP\/PTEN Circuit","volume":"1","author":"Lin","year":"2010","journal-title":"Genes Cancer"},{"key":"key20180107224724_b13-or-37-02-0737","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1158\/1535-7163.MCT-10-0799","article-title":"BRAFV600E: Implications for carcinogenesis and molecular therapy","volume":"10","author":"Cantwell-Dorris","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"key20180107224724_b14-or-37-02-0737","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00280-008-0881-9","article-title":"Cancer and the tumor microenvironment: A review of an essential relationship","volume":"63","author":"Mbeunkui","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107224724_b15-or-37-02-0737","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pharmthera.2012.10.003","article-title":"Tumor stroma as targets for cancer therapy","volume":"137","author":"Zhang","year":"2013","journal-title":"Pharmacol Ther"},{"key":"key20180107224724_b16-or-37-02-0737","doi-asserted-by":"crossref","first-page":"882","DOI":"10.18632\/oncotarget.594","article-title":"Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma","volume":"3","author":"Bevelacqua","year":"2012","journal-title":"Oncotarget"},{"key":"key20180107224724_b17-or-37-02-0737","first-page":"e773","article-title":"Tumor talk: Understanding the conversation between the tumor and its microenvironment","volume":"2","author":"Whipple","year":"2015","journal-title":"Cancer Cell Microenviron"},{"key":"key20180107224724_b18-or-37-02-0737","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11912-008-0067-y","article-title":"Melanoma and the tumor microenvironment","volume":"10","author":"Villanueva","year":"2008","journal-title":"Curr Oncol Rep"},{"key":"key20180107224724_b19-or-37-02-0737","doi-asserted-by":"crossref","first-page":"10164","DOI":"10.1158\/0008-5472.CAN-05-2497","article-title":"Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment","volume":"65","author":"Seftor","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107224724_b20-or-37-02-0737","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1158\/0008-5472.CAN-06-0731","article-title":"Influence of the microenvironment on melanoma cell fate determination and phenotype","volume":"66","author":"Postovit","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107224724_b21-or-37-02-0737","first-page":"29","article-title":"New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: Outside-in signaling and relationship to tumor progression","volume":"1825","author":"Bauvois","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"key20180107224724_b22-or-37-02-0737","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1055-3207(18)30071-1","article-title":"The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis","volume":"10","author":"Stetler-Stevenson","year":"2001","journal-title":"Surg Oncol Clin N Am"},{"key":"key20180107224724_b23-or-37-02-0737","doi-asserted-by":"crossref","first-page":"933","DOI":"10.18632\/aging.100951","article-title":"MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma","volume":"8","author":"Falzone","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"key20180107224724_b24-or-37-02-0737","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbamcr.2015.08.010","article-title":"Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy","volume":"1863","author":"Candido","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"key20180107224724_b25-or-37-02-0737","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.cmr.0000215033.92693.73","article-title":"Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines","volume":"16","author":"Shellman","year":"2006","journal-title":"Melanoma Res"},{"key":"key20180107224724_b26-or-37-02-0737","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3892\/ijo.2013.2159","article-title":"In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors","volume":"44","author":"Roomi","year":"2014","journal-title":"Int J Oncol"},{"key":"key20180107224724_b27-or-37-02-0737","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3892\/or.2014.3001","article-title":"Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients","volume":"31","author":"Heo","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180107224724_b28-or-37-02-0737","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/08820139.2011.557795","article-title":"Overexpression of MMP-9 contributes to invasiveness of prostate cancer cell line LNCaP","volume":"40","author":"Aalinkeel","year":"2011","journal-title":"Immunol Invest"},{"key":"key20180107224724_b29-or-37-02-0737","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/onc.2011.240","article-title":"MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis","volume":"31","author":"Chou","year":"2012","journal-title":"Oncogene"},{"key":"key20180107224724_b30-or-37-02-0737","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cyto.2013.02.017","article-title":"IL-6-174 G > C and MMP-9-1562 C > T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients","volume":"62","author":"Malaponte","year":"2013","journal-title":"Cytokine"},{"key":"key20180107224724_b31-or-37-02-0737","first-page":"1363","article-title":"Matrix metalloproteinase-2 and matrix metalloproteinase-9 type IV collagenases in serum of patients with pleural effusions","volume":"26","author":"Di Carlo","year":"2005","journal-title":"Int J Oncol"},{"key":"key20180107224724_b32-or-37-02-0737","first-page":"565","article-title":"Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells","volume":"9","author":"Kato","year":"2002","journal-title":"Oncol Rep"},{"key":"key20180107224724_b33-or-37-02-0737","first-page":"69","article-title":"The role of gelatinases in colorectal cancer progression and metastasis","volume":"1705","author":"Mook","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"key20180107224724_b34-or-37-02-0737","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3892\/or_00000831","article-title":"Co-regulated expression of matrix metalloproteinase-2 and transforming growth factor-beta in melanoma development and progression","volume":"24","author":"Malaponte","year":"2010","journal-title":"Oncol Rep"},{"key":"key20180107224724_b35-or-37-02-0737","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1158\/1078-0432.CCR-04-2478","article-title":"High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma","volume":"11","author":"Nikkola","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107224724_b36-or-37-02-0737","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jcp.21835","article-title":"Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells","volume":"221","author":"Chen","year":"2009","journal-title":"J Cell Physiol"},{"key":"key20180107224724_b37-or-37-02-0737","doi-asserted-by":"crossref","first-page":"44926","DOI":"10.1074\/jbc.M103334200","article-title":"Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells","volume":"276","author":"Philip","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107224724_b38-or-37-02-0737","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1158\/1078-0432.CCR-08-0870","article-title":"Activation of the osteopontin\/matrix metalloproteinase-9 pathway correlates with prostate cancer progression","volume":"14","author":"Castellano","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107224724_b39-or-37-02-0737","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbamcr.2015.09.018","article-title":"Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression","volume":"1863","author":"Malaponte","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"key20180107224724_b40-or-37-02-0737","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10555-007-9104-9","article-title":"Osteopontin: Regulation in tumor metastasis","volume":"27","author":"Wai","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107224724_b41-or-37-02-0737","first-page":"61","article-title":"The metastasis gene osteopontin: A candidate target for cancer therapy","volume":"1552","author":"Weber","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"key20180107224724_b42-or-37-02-0737","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cytogfr.2006.09.010","article-title":"The regulation and role of osteopontin in malignant transformation and cancer","volume":"17","author":"El-Tanani","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20180107224724_b43-or-37-02-0737","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4161\/cbt.4.11.2087","article-title":"Elevated Serum Levels of Osteopontin in HCV-Associated Lymphoproliferative Disorders","volume":"4","author":"Libra","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"key20180107224724_b44-or-37-02-0737","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MPA.0b013e31825e354d","article-title":"Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma","volume":"42","author":"Poruk","year":"2013","journal-title":"Pancreas"},{"key":"key20180107224724_b45-or-37-02-0737","doi-asserted-by":"crossref","first-page":"11799","DOI":"10.1007\/s13277-014-2314-1","article-title":"Correlation between ovarian neoplasm and serum levels of osteopontin: A meta-analysis","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol"},{"key":"key20180107224724_b46-or-37-02-0737","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.3748\/wjg.v18.i30.3923","article-title":"Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers","volume":"18","author":"Cao","year":"2012","journal-title":"World J Gastroenterol"},{"key":"key20180107224724_b47-or-37-02-0737","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1007\/s11033-010-0671-4","article-title":"Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells","volume":"38","author":"Lin","year":"2011","journal-title":"Mol Biol Rep"},{"key":"key20180107224724_b48-or-37-02-0737","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cncr.23147","article-title":"Osteopontin as a molecular prognostic marker for melanoma","volume":"112","author":"Rangel","year":"2008","journal-title":"Cancer"},{"key":"key20180107224724_b49-or-37-02-0737","doi-asserted-by":"crossref","first-page":"xiv","DOI":"10.1111\/j.0022-202X.2005.23741.x","article-title":"Osteopontin in melanocytic lesions - a first step towards invasion?","volume":"124","author":"Sturm","year":"2005","journal-title":"J Invest Dermatol"},{"key":"key20180107224724_b50-or-37-02-0737","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.1007\/s13277-015-3495-y","article-title":"The role of osteopontin expression in melanoma progression","volume":"36","author":"Kiss","year":"2015","journal-title":"Tumour Biol"},{"key":"key20180107224724_b51-or-37-02-0737","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.0022-202X.2005.23680.x","article-title":"Osteopontin expression correlates with melanoma invasion","volume":"124","author":"Zhou","year":"2005","journal-title":"J Invest Dermatol"},{"key":"key20180107224724_b52-or-37-02-0737","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.prp.2010.11.004","article-title":"Osteopontin expression correlates with nuclear factor-\u03baB activation and apoptosis downregulation in clear cell renal cell carcinoma","volume":"207","author":"Matu\u0161an-Ilija\u0161","year":"2011","journal-title":"Pathol Res Pract"},{"key":"key20180107224724_b53-or-37-02-0737","doi-asserted-by":"crossref","first-page":"28593","DOI":"10.1074\/jbc.M303445200","article-title":"Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase\/Akt signaling pathways in breast cancer cells","volume":"278","author":"Das","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180107224724_b54-or-37-02-0737","first-page":"909","article-title":"Osteopontin stimulates melanoma growth and lung metastasis through NIK\/MEKK1-dependent MMP-9 activation pathways","volume":"18","author":"Rangaswami","year":"2007","journal-title":"Oncol Rep"},{"key":"key20180107224724_b55-or-37-02-0737","doi-asserted-by":"crossref","first-page":"38921","DOI":"10.1074\/jbc.M404674200","article-title":"Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK\/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation","volume":"279","author":"Rangaswami","year":"2004","journal-title":"J Biol Chem"},{"key":"key20180107224724_b56-or-37-02-0737","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3892\/ijo.2014.2393","article-title":"Osteopontin promotes the progression of gastric cancer through the NF-\u03baB pathway regulated by the MAPK and PI3K","volume":"45","author":"Liu","year":"2014","journal-title":"Int J Oncol"},{"key":"key20180107224724_b57-or-37-02-0737","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.oraloncology.2011.03.017","article-title":"Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population","volume":"47","author":"Polesel","year":"2011","journal-title":"Oral Oncol"},{"key":"key20180107224724_b58-or-37-02-0737","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0960-894X(00)00114-1","article-title":"Synthesis of NF-kappaB activation inhibitors derived from epoxyquinomicin C","volume":"10","author":"Matsumoto","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"key20180107224724_b59-or-37-02-0737","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s12263-015-0460-8","article-title":"Peripheral mononuclear blood cells contribute to the obesity-associated inflammatory state independently of glycemic status: involvement of the novel proinflammatory adipokines chemerin, chitinase-3-like protein 1, lipocalin-2 and osteopontin","volume":"10","author":"Catal\u00e1n","year":"2015","journal-title":"Genes Nutr"},{"key":"key20180107224724_b60-or-37-02-0737","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00403-012-1251-3","article-title":"Modification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-\u03b1 therapy","volume":"304","author":"Buommino","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"key20180107224724_b61-or-37-02-0737","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10585-010-9307-2","article-title":"Gene signature of the metastatic potential of cutaneous melanoma: Too much for too little?","volume":"27","author":"T\u00edm\u00e1r","year":"2010","journal-title":"Clin Exp Metastasis"},{"key":"key20180107224724_b62-or-37-02-0737","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.acthis.2008.11.022","article-title":"Molecular interactions in cancer cell metastasis","volume":"112","author":"Brooks","year":"2010","journal-title":"Acta Histochem"},{"key":"key20180107224724_b63-or-37-02-0737","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.gde.2007.12.006","article-title":"Microenvironmental regulation of cancer development","volume":"18","author":"Hu","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"key20180107224724_b64-or-37-02-0737","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10719-006-7927-1","article-title":"Nuclear factor inducing kinase: A key regulator in osteopontin- induced MAPK\/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation","volume":"23","author":"Rangaswami","year":"2006","journal-title":"Glycoconj J"},{"key":"key20180107224724_b65-or-37-02-0737","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tcb.2005.12.005","article-title":"Osteopontin: Role in cell signaling and cancer progression","volume":"16","author":"Rangaswami","year":"2006","journal-title":"Trends Cell Biol"},{"key":"key20180107224724_b66-or-37-02-0737","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/sj.bjc.6605849","article-title":"Melanoma sentinel node biopsy and prediction models for relapse and overall survival","volume":"103","author":"Mitra","year":"2010","journal-title":"Br J Cancer"},{"key":"key20180107224724_b67-or-37-02-0737","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cytogfr.2015.06.001","article-title":"Dynamic aberrant NF-\u03baB spurs tumorigenesis: A new model encompassing the microenvironment","volume":"26","author":"Vlahopoulos","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20180107224724_b68-or-37-02-0737","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"key20180107224724_b69-or-37-02-0737","first-page":"614","article-title":"Targeting the Raf\/MEK\/ERK pathway with small-molecule inhibitors","volume":"9","author":"McCubrey","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"key20180107224724_b70-or-37-02-0737","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","article-title":"Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy","volume":"1799","author":"Gupta","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"key20180107224724_b71-or-37-02-0737","doi-asserted-by":"crossref","first-page":"e0132496","DOI":"10.1371\/journal.pone.0132496","article-title":"Increased Levels of NF-\u03baB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis","volume":"10","author":"Malaponte","year":"2015","journal-title":"PLoS One"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2017.5362\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T06:05:55Z","timestamp":1568700355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2017.5362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":71,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,1,10]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3892\/or.2017.5362"],"URL":"https:\/\/doi.org\/10.3892\/or.2017.5362","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}